Consistent with these findings, our experiment found that after treatment with donepezil, down-regulated expression of ASC and caspase-1 occurred in the brains of AD mice, and decreased IL-1β and ROS was also observed, supporting a role for donepezil in modulating the NLRP3 inflammasome. Here, NLRP3 is linked to Alzheimer disease.